SI2350093T1 - Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence - Google Patents

Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence

Info

Publication number
SI2350093T1
SI2350093T1 SI200930353T SI200930353T SI2350093T1 SI 2350093 T1 SI2350093 T1 SI 2350093T1 SI 200930353 T SI200930353 T SI 200930353T SI 200930353 T SI200930353 T SI 200930353T SI 2350093 T1 SI2350093 T1 SI 2350093T1
Authority
SI
Slovenia
Prior art keywords
tetrahydrothienopyridines
kcnq2
epilepsy
modulators
substituted
Prior art date
Application number
SI200930353T
Other languages
English (en)
Inventor
Sven Kuhnert
Gregor Bahrenberg
Achim Kless
Beatrix Merla
Klaus Schiene
Wolfgang Schroder
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of SI2350093T1 publication Critical patent/SI2350093T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SI200930353T 2008-10-24 2009-10-22 Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence SI2350093T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08018617 2008-10-24
PCT/EP2009/007567 WO2010046108A1 (de) 2008-10-24 2009-10-22 Substituierte 4,5,6,7-tetrahydrothienopyridine als kcnq2/3 modulatoren zur behandlung von schmerz, epilepsie und harninkontinenz
EP09747793A EP2350093B1 (de) 2008-10-24 2009-10-22 Substituierte 4,5,6,7-tetrahydrothienopyridine als kcnq2/3 modulatoren zur behandlung von schmerz, epilepsie und harninkontinenz

Publications (1)

Publication Number Publication Date
SI2350093T1 true SI2350093T1 (sl) 2012-11-30

Family

ID=40383750

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930353T SI2350093T1 (sl) 2008-10-24 2009-10-22 Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence

Country Status (15)

Country Link
US (1) US20100105722A1 (sl)
EP (1) EP2350093B1 (sl)
JP (1) JP2012506395A (sl)
AU (1) AU2009306722A1 (sl)
BR (1) BRPI0919898A2 (sl)
CA (1) CA2739740A1 (sl)
CY (1) CY1113373T1 (sl)
DK (1) DK2350093T3 (sl)
ES (1) ES2392758T3 (sl)
HR (1) HRP20120822T1 (sl)
MX (1) MX2011003849A (sl)
PL (1) PL2350093T3 (sl)
PT (1) PT2350093E (sl)
SI (1) SI2350093T1 (sl)
WO (1) WO2010046108A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2537628T3 (es) 2010-08-27 2015-06-10 Grünenthal GmbH 2-Oxiquinolin-3-carboxamidas sustituidas como moduladores de KCNQ2/3
TWI552750B (zh) 2010-08-27 2016-10-11 歌林達股份有限公司 作為ｋｃｎｑ２／３鉀離子通道調節劑之經取代之２－氧基－及2－硫基－二氫喹啉－３－羧醯胺
EP2609084A1 (en) * 2010-08-27 2013-07-03 Grünenthal GmbH Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
TWI565465B (zh) * 2010-08-27 2017-01-11 歌林達股份有限公司 作為ｋｃｎｑ２／３調節劑之被取代之喹啉－３－甲醯胺
BR112013005056A2 (pt) 2010-09-01 2016-05-31 Gruenenthal Gmbh 1-oxo-di-hidroisoquinolina-3-carboxamidas substituídas como moduladores kcnq2/3
US9168259B2 (en) 2010-10-20 2015-10-27 Grünenthal GmbH Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
BR112013010957A2 (pt) 2010-10-20 2016-08-30 Gruenenthal Gmbh 6-amino-nicotinamidas substituídas como moduladores kcnq2/3
JP6117334B2 (ja) * 2012-03-23 2017-04-19 メモリアル スローン−ケタリング キャンサー センター 膵臓癌および関連するがんの５−アシル−６，７−ジヒドロチエノ［３，２−ｃ］ピリジンでの処置
CN104428287A (zh) 2012-04-18 2015-03-18 格吕伦塔尔有限公司 作为kcnq2/3调节剂的取代的含有oh基团的6-氨基-烟酰胺
EP2844645A1 (en) 2012-04-18 2015-03-11 Grünenthal GmbH Substituted 4-aminobenzamides as kcnq2/3 modulators
MX2015006689A (es) 2012-11-28 2015-08-20 Grünenthal GmbH Carboxamidas especificas como moduladores de kcnq2/3.
WO2014082738A1 (en) 2012-11-28 2014-06-05 Grünenthal GmbH Heteroquinoline-3-carboxamides as kcnq2/3 modulators
US9248122B2 (en) 2012-11-28 2016-02-02 Grünenthal GmbH Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
WO2021212010A2 (en) * 2020-04-17 2021-10-21 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections
US11931356B1 (en) 2022-11-30 2024-03-19 The Trustees Of Indiana University Compositions and methods for treating human papilloma virus infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
MXPA03007397A (es) * 2001-02-20 2003-12-04 Bristol Myers Squibb Co Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas.
US7723523B2 (en) * 2004-05-28 2010-05-25 4Sc Ag Tetrahydropyridothiophenes
AU2005251485A1 (en) * 2004-06-11 2005-12-22 4Sc Ag Tetrahydropyridothiophenes for treating hyperproliferative disorders
DE102006049452A1 (de) * 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
WO2009001128A1 (en) * 2007-06-26 2008-12-31 Astrazeneca Ab 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors

Also Published As

Publication number Publication date
BRPI0919898A2 (pt) 2016-02-16
HRP20120822T1 (hr) 2012-11-30
PL2350093T3 (pl) 2013-01-31
PT2350093E (pt) 2012-11-02
AU2009306722A1 (en) 2010-04-29
CY1113373T1 (el) 2016-06-22
MX2011003849A (es) 2011-05-23
US20100105722A1 (en) 2010-04-29
CA2739740A1 (en) 2010-04-29
WO2010046108A1 (de) 2010-04-29
DK2350093T3 (da) 2012-11-12
EP2350093A1 (de) 2011-08-03
JP2012506395A (ja) 2012-03-15
ES2392758T3 (es) 2012-12-13
EP2350093B1 (de) 2012-10-03

Similar Documents

Publication Publication Date Title
PL2350093T3 (pl) Podstawione 4,5,6,7-tetrahydrotienopirydyny jako modulatory KCNQ2/3 do leczenia bólu, padaczki i nietrzymania moczu
EP2173275A4 (en) APPARATUS AND METHOD FOR TREATING INCONTINENCE TO EFFORT
EP2346416A4 (en) METHOD AND DEVICES FOR TREATING SPINAL STENOSIS
IL202015A0 (en) Methods and compositions for treating skin conditions
EP2170309A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES
IL209032A0 (en) Compositions and methods for treating digestive disorders
EP2094180A4 (en) METHODS AND SYSTEMS FOR TREATING TISSUE SITES USING ELECTROCORPORATION
EP2260109A4 (en) METHODS AND COMPOSITIONS BASED ON MICRO-RNA FOR DIAGNOSING, PROGNOSING AND TREATING PROSTATE-RELATED DISORDERS
EP2088952A4 (en) METHODS AND DEVICES FOR PROCESSING FABRICS
EP2229171A4 (en) METHOD AND COMPOSITIONS FOR TREATING POST-OPERATIVE PAIN WITH A LOCAL ANESTHETIC
EP2176283A4 (en) METHOD AND COMPOSITIONS FOR TREATING BRAIN DISEASES
EP2068999A4 (en) IMPLANTABLE DEVICE AND METHOD FOR THE TREATMENT OF STERILE CURVES AND OTHER DISEASES
EP2083857A4 (en) METHOD FOR TREATING INTERFERENCE IN CONNECTION WITH MICA
EP2073752A4 (en) IMPLANTABLE DEVICES FOR THE TREATMENT OF INCONTINENCE, AND METHODS OF USE
ZA200902213B (en) Urinary incontinence device applicator
HK1162366A1 (en) Devices and methods for treating and or preventing diseases
IL207132A0 (en) Composition and method for seed treatment use
IL202424A (en) Telomerase activator compounds for use in the treatment of disorders and related conditions
GB0718523D0 (en) Agricultural treatment
PL2106774T3 (pl) Regulowany aplikator dla urządzeń stosowanych przy nietrzymaniu moczu
EP2244690A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DRESSES
EP2272472A4 (en) Excrement treating apparatus
HK1232162A1 (zh) 治療疼痛症狀及其它失調的化合物
EP2051727A4 (en) METHOD FOR THE TREATMENT OF FIBROTIC DISEASES AND KELOIDS
HK1139856A1 (en) Methods for treating acute pain